Posted in | News | Biofuels | Green Aviation

Solena Fuels Selects Oxford Catalysts Group’s Microchannel Fischer-Tropsch Technology

Solena Fuels has chosen Oxford Catalysts Group’s microchannel Fischer-Tropsch technology for utilization in a biomass-to-liquids (BTL) project being developed in the United Kingdom.

Fluor advised Solena to select the microchannel Fischer-Tropsch technology. BTL process is utilized for conversion of waste biomass into superior-quality liquid fuels, which are fully compatible with fuels based on petroleum. The fuels generated through the BTL process find use in present engines and infrastructure.

GreenSky London is the name of the BTL project, which will be involved in the conversion of waste biomass into sustainable jet fuel, with an objective to become the first industrial-scale sustainable jet fuel plant in Europe. British Airways is the project’s key partner, which plans to power a portion of its fleet by the low-carbon fuel by 2015.

Moreover, Solena and Oxford Catalysts Group have team up to deliver microchannel Fischer-Tropsch units for use in Solena’s upcoming BTL projects with shipping companies and airlines. These projects include GreenSky Stockholm, GreenSky Rome and GreenSky California.

Oxford Catalysts Group’s Commercial Director, Jeff McDaniel stated that the selection of the company’s microchannel technology for this project over traditional Fischer-Tropsch technology is a testament to the company’s technology. The company is happy to make a contribution in the GreenSky London project and to lend its support to British Airways’ sustainable aviation strategy and Solena’s plan to roll out multiple sustainable fuel plants across the globe.

Solena Fuels’ Chief Executive Officer, Dr. Robert Do commented that the company conducted a thorough assessment of existing providers for the Fischer-Tropsch technology, a crucial component of the company’s integrated BTL solution based on the advice from Flour. Oxford Catalysts’ microchannel technology delivers modular sizing as well as the benefits of high-efficiency, fixed bed reactors.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, March 01). Solena Fuels Selects Oxford Catalysts Group’s Microchannel Fischer-Tropsch Technology. AZoCleantech. Retrieved on November 21, 2024 from https://www.azocleantech.com/news.aspx?newsID=16989.

  • MLA

    Thomas, G.P.. "Solena Fuels Selects Oxford Catalysts Group’s Microchannel Fischer-Tropsch Technology". AZoCleantech. 21 November 2024. <https://www.azocleantech.com/news.aspx?newsID=16989>.

  • Chicago

    Thomas, G.P.. "Solena Fuels Selects Oxford Catalysts Group’s Microchannel Fischer-Tropsch Technology". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=16989. (accessed November 21, 2024).

  • Harvard

    Thomas, G.P.. 2019. Solena Fuels Selects Oxford Catalysts Group’s Microchannel Fischer-Tropsch Technology. AZoCleantech, viewed 21 November 2024, https://www.azocleantech.com/news.aspx?newsID=16989.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.